Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, February 23, 2023

Nationwide Study Links Parkinson's Disease to Air Pollution

Well, your concern is probably the risk from your stroke. Have your doctor create protocols that eliminate your Parkinsons risk from your stroke. YOUR DOCTOR'S RESPONSIBILITY! 

Your risk of Parkinsons here:

Parkinson’s Disease May Have Link to Stroke March 2017

The latest here:

Nationwide Study Links Parkinson's Disease to Air Pollution

Researchers identify a hot spot in the Mississippi-Ohio River Valley

 An aerial photo of Denver, Colorado with the Rocky Mountain range in the distance.

Researchers found a nationwide association between incident Parkinson's disease and air pollution, which varied in strength by region, and identified a hot spot in the Mississippi-Ohio River Valley.

The relative risk for incident Parkinson's increased by 25% (95% CI 23-26) comparing counties with the lowest to the highest quartile of PM2.5 (fine particulate matter less than 2.5 microns in diameter) throughout the U.S., reported Brittany Krzyzanowski, PhD, of the Barrow Neurological Institute in Phoenix, in an abstract released in advance of the American Academy of Neurologyopens in a new tab or window annual meeting.

The strongest association between PM2.5 and incident Parkinson's was in the Rocky Mountain region, including Lake County, Colorado. Fine particulate matter was also associated with higher rates of Parkinson's in a Mississippi-Ohio River Valley hot spot that includes Tennessee and Kentucky, but the relationship was weaker due to an apparent ceiling effect.

The Mississippi-Ohio River Valley region has some of the highest levels of particulate matter in the nation, Krzyzanowski told MedPage Today.

"Finding a relatively weaker association where we have some of the highest Parkinson's disease risks and fine particulate matter levels is consistent with the threshold effect we observed in our data," she said.

"In the Mississippi-Ohio River Valley, for example, Parkinson's disease risk increases with increasing air pollution exposure until about 15 µg/m3 of fine particulate matter, where Parkinson's disease risk seems to plateau," she added.

The findings add important evidence to the role that air pollution may play in Parkinson's disease, noted Ray Dorsey, MD, of the University of Rochester in New York, who wasn't involved with the study.

Recent research has demonstrated that fine particles and the toxicants they may be carrying cause damage to mitochondriaopens in a new tab or window, Dorsey pointed out. "Other environmental toxicants, such as certain pesticides and dry cleaning chemicals, hurt mitochondria and are also inhaled," he told MedPage Today.

"This all suggests a possible common mechanism of injury and portal of entry for environmental toxicants," he added. "The answer to what is fueling the rise of many brain diseases may be under our noses."

Recent studies have tied Parkinson's with nitrogen dioxideopens in a new tab or window (NO2) exposure, he noted. In 2022, researchers published an environmental agendaopens in a new tab or window to help address contaminants like pesticides, metals, and industrial chemicals that are implicated in Parkinson's disease.

Krzyzanowski and co-authors conducted a geographic study of 22.5 million Medicare beneficiaries, including 83,674 people with incident Parkinson's disease in 2009. They geocoded beneficiaries to county and zip code of residence in the contiguous U.S., and performed an individual-level case-control analysis to verify county-level results.

People in the quartile with the highest fine particulate matter had an average annual exposure of 19 µg/m3; those in the lowest quartile had an average annual exposure of 5 µg/m3. Incident Parkinson's cases were 434 per 100,000 population in the highest PM2.5 quartile and 359 per 100,000 in the lowest.

Individual-level data confirmed that Parkinson's incidence increased by 25% (95% CI 20-29) when comparing the lowest to the highest decile of PM2.5.

"By mapping nationwide levels of Parkinson's disease and linking them to air pollution, we hope to create a greater understanding of the regional risks and inspire leaders to take steps to lower risk of disease by reducing levels of air pollution," Krzyzanowski said in a statement.

A study limitation is that fine particulate matter contains a variety of airborne pollutants, some of which may be more toxic than others, Krzyzanowski acknowledged. Air pollution is tied to other health risks including dementia, which may reduce Parkinson's diagnoses and explain the relatively weaker association found in the Mississippi-Ohio River Valley, she added.

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Disclosures

This study was supported by the U.S. Department of Defense, the National Institutes of Health-National Institute of Environmental Health Sciences, and the Michael J. Fox Foundation for Parkinson's Research.

Primary Source

American Academy of Neurology

Source Reference: opens in a new tab or windowKrzyzanowski B, et al "Fine particulate matter and Parkinson disease risk in Medicare beneficiaries" AAN 2023.

No comments:

Post a Comment